Spruce Biosciences, Inc. (SPRB) Operating cash flow 2019–2025
Spruce Biosciences, Inc. (SPRB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$33.3MFY2025 · since FY2019: -$12.6M → -$33.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$33.3M | +40.4% |
| FY2024 | -$56.0M | -68.2% |
| FY2023 | -$33.3M | +20.2% |
| FY2022 | -$41.7M | -16.2% |
| FY2021 | -$35.9M | -30.4% |
| FY2020 | -$27.5M | -118.1% |
| FY2019 | -$12.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice